The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(Difluoromethyl)-4-methoxy-1-[4-(4-morpholinyl)-6-(4-[[2-(4-morpholinyl)ethyl]sulfonyl]-1-piperazinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole Hydrochloride ID: ALA4513717
PubChem CID: 67546448
Max Phase: Preclinical
Molecular Formula: C26H36ClF2N9O5S
Molecular Weight: 623.69
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCN(S(=O)(=O)CCN3CCOCC3)CC2)n1.Cl
Standard InChI: InChI=1S/C26H35F2N9O5S.ClH/c1-40-20-4-2-3-19-21(20)29-23(22(27)28)37(19)26-31-24(30-25(32-26)35-11-16-42-17-12-35)34-5-7-36(8-6-34)43(38,39)18-13-33-9-14-41-15-10-33;/h2-4,22H,5-18H2,1H3;1H
Standard InChI Key: YEZMZPRIDQMLPQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
44 48 0 0 0 0 0 0 0 0999 V2000
13.0073 -19.2033 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9.1501 -19.5012 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7456 -18.7954 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.3366 -19.4986 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5055 -16.3397 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5044 -17.1592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2124 -17.5682 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9221 -17.1587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9192 -16.3361 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2106 -15.9308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7963 -17.5672 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0926 -17.1536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3867 -17.5582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3819 -18.3757 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0891 -18.7870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8012 -18.3809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2082 -15.1136 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8611 -14.6306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6072 -13.8539 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5399 -14.6343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7897 -13.8595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2442 -13.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4487 -13.4296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2016 -14.2086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7488 -14.8070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5577 -15.0580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5358 -15.8749 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.2761 -14.6685 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.4941 -12.4797 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2929 -12.3072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6303 -17.5665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6271 -18.3836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3313 -18.7913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0409 -18.3853 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0420 -17.5672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3333 -17.1549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4564 -18.3891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1623 -18.8007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8718 -18.3951 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5772 -18.8094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2845 -18.4073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2922 -17.5898 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5864 -17.1761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8729 -17.5798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 2 2 0
4 3 2 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
6 11 1 0
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
10 17 1 0
17 18 1 0
18 19 2 0
19 21 1 0
20 17 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
18 26 1 0
26 27 1 0
26 28 1 0
22 29 1 0
29 30 1 0
8 31 1 0
31 32 1 0
31 36 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
34 3 1 0
3 37 1 0
37 38 1 0
38 39 1 0
39 40 1 0
39 44 1 0
40 41 1 0
41 42 1 0
42 43 1 0
43 44 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 623.69Molecular Weight (Monoisotopic): 623.2450AlogP: 0.78#Rotatable Bonds: 9Polar Surface Area: 131.28Molecular Species: NEUTRALHBA: 13HBD: ┄#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 6.07CX LogP: 1.96CX LogD: 1.94Aromatic Rings: 3Heavy Atoms: 43QED Weighted: 0.33Np Likeness Score: -1.42
References 1. Giddens AC, Gamage SA, Kendall JD, Lee WJ, Baguley BC, Buchanan CM, Jamieson SMF, Dickson JMJ, Shepherd PR, Denny WA, Rewcastle GW.. (2019) Synthesis and biological evaluation of solubilized sulfonamide analogues of the phosphatidylinositol 3-kinase inhibitor ZSTK474., 27 (8): [PMID:30850264 ] [10.1016/j.bmc.2019.02.050 ]